# Ernexa Therapeutics Inc.: Form DEF 14A, filed Aug 12, 2022

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: DEF 14A
- Filed: 2022-08-12
- Accepted by EDGAR: Aug 12, 2022, 16:15 ET
- Period: 2022-09-21
- Accession: 0001140361-22-029433
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036122029433/ny20004814x4_def14a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036122029433/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036122029433/ny20004814x4_def14a.htm

Filed Aug 12, 2022.
Source: SEC EDGAR, the filing index for accession 0001140361-22-029433. Last ingested by Listed: Nov 6, 2026, 17:52 ET. No prices; not investment advice.